- REGN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $371.2 million.
- REGN has traded 8,135 shares today.
- REGN is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in REGN with the Ticky from Trade-Ideas. See the FREE profile for REGN NOW at Trade-Ideas More details on REGN: Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. REGN has a PE ratio of 163. Currently there are 12 analysts that rate Regeneron Pharmaceuticals a buy, no analysts rate it a sell, and 7 rate it a hold. The average volume for Regeneron Pharmaceuticals has been 824,200 shares per day over the past 30 days. Regeneron has a market cap of $51.6 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.71 and a short float of 5.9% with 6.16 days to cover. Shares are up 25.3% year-to-date as of the close of trading on Wednesday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.